FDA Investigator Charles A Snipes, PhD

Charles A Snipes, PhD has conducted inspections on 11 sites in 1 countries as of 03 Dec 2007. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
11
Last Inspection Date:
03 Dec 2007
Investigator Role:
FDA Investigation Participant
Redica ID:
100000314
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Charles A Snipes, PhD:
Amanda E Lewin, PhD, Amber G Chung, Amber G Wardwell, Ana P Barido, Andrea A Branche, Andrew M Barlow, Andrew R Wasko, Annemarie Bodnar, Arianne L Motter, Arindam Dasgupta, PhD, Barbara A Rusin, Brandon L Mariner, Brian D Nicholson, Brian R Yaun, Bruce H Mccullough, Byron Ho, DVM, Byungja E Marciante, Candice C Mandera, Carla C Tuite, Carol Rivera Lopez, PhD, Charles M Edwards, Charles M Kerns, BLT DO, Charles R Bonapace, PhD, Chelsea W Lamm, Christine M Whitby, CSO, Corey K Reno, Courtney N Long, Ct Viswanathan, PhD, Cynthia A Harris, MD, RN, Daniel J Grabicki, Darin S Wiegers, David K Glasgow, David L Chon, David P Vanhouten, Dawn C Olenjack, Denise M Visco, Investigator, Dina A Tallman, Douglas W Gronski, Dr. Abhijit Raha, PhD, Dr. Hansong Chen, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dylan D Yao, MD, PhD, Edward D Harris, Edward D Vains, Eric S Pittman, Erin M Mcdowell, Gabrielle J Swain, Gajendiran Mahadevan, PhD, Gary J Hagan, Himanshu Gupta, PhD, Humberto Z Gomez, Ita Yuen, PhD, James W Plucinski, Jeanne J Thai, Jennifer C Adams, John A Kadavil, PhD, Joseph R Haynes, Joy Rkozlowski Klena, Jyoti B Patel, PhD, Kara A Scheibner, PhD, Kathleen A Schelble, Kathleen S Tormey, Kent A Conforti, Kristy A Zielny, Kujtim Sadiku, Lakisha M Williams, Larry K Austin, Laureen F Kononen, Lequita M Mayhew, Leslie A Paul, Lisa Hayka, Lisa P Oakes, LT Melanie M Mayor, USPHS, Marcelo O Mangalindan, Jr, Marcia A Worley, Margaret Torres Vazquez, Martin J Guardia, Mary Jeanet Mcgarry, Marya F Ricks, Matthew C Watson, Melkamu Getie Kebtie, PhD, Michael F Skelly, PhD, Michael Serrano, Nancy A Bellamy, Natalie A Mickelsen, DVM, Nicholas A Violand, Niraj R Mehta, PhD, Rebecca T Davis, Regina T Brown, Renee L Rice, PhD, Rory K Geyer, Russell J Glapion, Sandra S Saniga, Scott B Laufenberg, Shirley H Isbill, Sripal R Mada, PhD, Stacey A Priest, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Stuart W Russell, Susanne M Richardson, MS RAC, Tara C Alcazar, Thea C Grome, Tracey Asinjen Wiersma, Twana R Chandler, Victor J Gangi, Vincent F Cafiso, William D Tingley, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Young M Yoon, Yuanyuan Li

Charles A Snipes, PhD's Documents

Publish Date Document Type Title
December, 2007 EIR Labcorp Bedford LLC. - EIR, 2007-12-07
January, 2000 EIR Bristol-Myers Squibb Company - EIR, 2000-01-28
March, 2001 FDA 483 G.D. Searle & Co. - Form 483, 2001-03-22
September, 2005 FDA 483 Response Pfizer, Inc. - Form 483R, 2005-09-15
May, 2007 FDA 483 Charles River Laboratories, Inc - Form 483, 2007-05-23
August, 2005 FDA 483 Charles River Laboratories - Form 483, 2005-08-26
September, 2005 FDA 483 Pfizer, Inc. - Form 483, 2005-09-15
December, 2007 FDA 483 Labcorp Bedford LLC. - Form 483, 2007-12-07
January, 2000 FDA 483 Bristol-Myers Squibb Company - Form 483, 2000-01-28
January, 2005 EIR IIT Research Institute - EIR, 2005-01-07
September, 2005 EIR Pfizer, Inc. - EIR, 2005-09-15
September, 2007 EIR BASi Gaithersburg, LLC - EIR, 2007-09-13
January, 2005 FDA 483 Response IIT Research Institute - Form 483R, 2005-02-04
March, 2001 EIR G.D. Searle & Co. - EIR, 2001-03-22
January, 2005 FDA 483 IIT Research Institute - Form 483, 2005-01-07
October, 2002 EIR Bristol-Meyers Squibb - EIR, 2002-10-11
December, 2007 FDA 483 Response Labcorp Bedford LLC. - Form 483R, 2007-12-13
August, 2000 EIR Ore Pharmaceuticals Inc - EIR, 2000-08-29
August, 2000 FDA 483 Ore Pharmaceuticals Inc - Form 483, 2000-08-29
April, 2004 FDA 483 New River Pharmaceuticals Inc - Form 483, 2004-04-27
August, 2005 EIR Charles River Laboratories - EIR, 2005-08-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more